company background image
2FJ0 logo

Pierrel DB:2FJ0 Stock Report

Last Price


Market Cap







28 Jan, 2024


Company Financials

2FJ0 Stock Overview

Pierrel S.p.A. engages in the development, production, registration, and licensing of synthetic drugs and medical devices for the oral health sector worldwide.

2FJ0 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance4/6
Financial Health3/6

Pierrel S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pierrel
Historical stock prices
Current Share Price€1.69
52 Week High€4.51
52 Week Low€0.094
11 Month Change2.42%
3 Month Change-6.63%
1 Year Change-58.32%
33 Year Change-55.53%
5 Year Change-51.71%
Change since IPO-53.38%

Recent News & Updates

Recent updates

Shareholder Returns

2FJ0DE PharmaceuticalsDE Market

Return vs Industry: 2FJ0 underperformed the German Pharmaceuticals industry which returned -27.5% over the past year.

Return vs Market: 2FJ0 underperformed the German Market which returned 0.1% over the past year.

Price Volatility

Is 2FJ0's price volatile compared to industry and market?
2FJ0 volatility
2FJ0 Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.4%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 2FJ0 has not had significant price volatility in the past 3 months.

Volatility Over Time: 2FJ0's weekly volatility has decreased from 12% to 5% over the past year.

About the Company


Pierrel S.p.A. engages in the development, production, registration, and licensing of synthetic drugs and medical devices for the oral health sector worldwide. It develops and markets dental anesthesia drugs under the Orabloc brand. The company also offers Goccles, a device for screening of the oral cavity.

Pierrel S.p.A. Fundamentals Summary

How do Pierrel's earnings and revenue compare to its market cap?
2FJ0 fundamental statistics
Market cap€92.83m
Earnings (TTM)€3.11m
Revenue (TTM)€26.96m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2FJ0 income statement (TTM)
Cost of Revenue€13.35m
Gross Profit€13.61m
Other Expenses€10.50m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date


Earnings per share (EPS)0.057
Gross Margin50.48%
Net Profit Margin11.53%
Debt/Equity Ratio109.7%

How did 2FJ0 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.